Project Grant K01DK142045
- The federal Project Grant award of $731,071 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to address the challenges preventing the provision of guideline-recommended diabetes care in the United States. The overarching goals are to: Describe differences in diabetes care receipt across individual, neighborhood, and insurance characteristics. Examine differences in...
- This $802,363 federal Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund a research study at Emory University from September 2025 to June 2030 to develop models for predicting the benefits of GLP-1 receptor agonist (GLP-1RA) treatments in preventing obesity-related cardiometabolic diseases. The study aims to use clinical...
- This $1,089,491 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to develop novel statistical methods, computational algorithms, and user-friendly software to study individual health trajectories relevant to disease onset and progression for large, diverse healthcare datasets like electronic medical records and biobanks. The research, to be conducted by the University of...
- This Project Grant award from the National Science Foundation (NSF) under the Mathematical and Physical Sciences (CFDA 47.049) federal grant program aims to improve diabetes care through the development of personalized digital twin models. The $716,195 award to the Research Foundation for the State University of New York (RF SUNY) will fund the creation of virtual patient models that can learn from wearable health sensors and guide real-time insulin delivery using automated medical devices....
- The federal Project Grant award of $843,485 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will support Duke University's evaluation of two novel, population-tailored health insurance designs and their impact on diabetes outcomes among working-age adults. The project aims to assess 10-year trends in the adoption of population-tailored insurance plans that provide more generous benefits to...
- This $882,180 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support a comprehensive research effort to analyze the largest dataset of rare genetic variants associated with diabetes. The Broad Institute, Inc. will lead this project to assess variant penetrance and integrate the genomic data with high-throughput cellular assays to...
- This Project Grant award of $714,440 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports a research study to advance precision diabetes medicine. The key objectives are to: Define subphenotypes of prediabetes and early type 2 diabetes based on underlying metabolic physiology, including insulin resistance, beta-cell function, incretin effect, and hepatic insulin resistance. Evaluate...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded a 5-year, $156,982 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to The Johns Hopkins University. The grant, titled "Improving Diabetes Prediction Using Clinical Factors, Proteomic Biomarkers, and Polygenic Risk Scores," will support Dr. Mary Rooney, an Assistant Research Professor at the Johns Hopkins Bloomberg School of Public Health,...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $847,498 to New York University (NYU) to develop and test an AI-driven clinical decision support system (CDS) and chatbot for managing patients on incretin mimetic medications (IMMs) for obesity treatment. The goal is to increase patient adherence and reduce the burden on healthcare...
- This federal Project Grant award of $152,379.00, provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop an AI-based framework that can identify digital biomarkers of glycemic control and patient-reported outcomes for personalized diabetes management. The goal is to leverage physiological signals, glucose management data, and...
This $161,664 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to develop "DREAM: BUILDING EQUITABLE PREDICTIVE MODELS FOR PERSONALIZED DIABETES PHARMACOTHERAPY." The project has three key objectives: (1) creating predictive models to estimate individualized outcomes like HbA1c, weight, and hypoglycemia for diabetes medication options, (2) characterizing variation in diabetes prescribing patterns across patient subgroups, and (3) improving model performance across subgroups. The award, with a performance period from September 2025 to July 2030, will provide the principal investigator, Dr. Polina Kukhareva, with training in diabetes pharmacotherapy, artificial intelligence, and subgroup-specific model evaluation. The project aims to leverage large electronic health record datasets, including EPIC COSMOS, TriNetX, and AHEAD, to develop enhanced diabetes treatment recommendations through predictive analytics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $161.7k | 9/17/25 |